Next |
home / stock / lctx / lctx message board
Subject | By | Source | When |
---|---|---|---|
https://www.mdpi.com/2079-7737/12/5/653 | chrismiss_everyday | investorshub | 04/30/2023 11:54:42 AM |
NEWS -- RG6501 (OpRegen®) Phase 1/2a Clinical Results | Paulness | investorshub | 04/26/2023 1:22:54 PM |
April 26, 2023 8:00 AM EDT | chrismiss_everyday | investorshub | 04/26/2023 1:03:46 PM |
A systems biology approach uncovers novel disease mechanisms | chrismiss_everyday | investorshub | 04/21/2023 12:44:56 PM |
ZZZZZZZZZZZZZ | abracky | investorshub | 04/18/2023 3:37:54 PM |
NEWS -- Lineage to Present at 2023 AAPS | Paulness | investorshub | 04/18/2023 12:27:33 PM |
https://www.christopherreeve.org/about-us/press-releases/lineage-and-the-christo | chrismiss_everyday | investorshub | 04/15/2023 10:11:19 PM |
https://investor.lineagecell.com/news-releases/news-release-details/lineage-and- | chrismiss_everyday | investorshub | 03/30/2023 1:11:09 PM |
NEWS -- RG6501 (OpRegen) Phase 1/2a Clinical Results | Paulness | investorshub | 03/20/2023 12:12:09 PM |
https://investor.lineagecell.com/node/22796/html 150,000 shares for Jillian H | chrismiss_everyday | investorshub | 03/11/2023 12:20:21 AM |
More durable and reliable progress. Good stuff. ARVO | chrismiss_everyday | investorshub | 03/10/2023 10:52:19 PM |
NEWS -- Q4 2022 Lineage Cell Therapeutics Inc | Paulness | investorshub | 03/10/2023 1:43:59 PM |
8K and 10K | chrismiss_everyday | investorshub | 03/10/2023 11:38:44 AM |
NEWS -- RG6501 (OpRegen) Phase 1/2a Results to | Paulness | investorshub | 03/06/2023 2:22:35 PM |
NEWS -- Lineage Cell Therapeutics to Report Fourth | Paulness | investorshub | 03/02/2023 2:17:12 PM |
NEWS -- Lineage Enters Into Option and License | Paulness | investorshub | 02/22/2023 2:44:39 PM |
Thanks for posting this Paulnessmissed it in my | chrismiss_everyday | investorshub | 02/09/2023 6:28:56 PM |
NEWS -- Lineage Provides Update on Auditory Neuronal | Paulness | investorshub | 02/08/2023 2:11:54 PM |
Presentation is up | chrismiss_everyday | investorshub | 01/23/2023 2:32:03 PM |
NEWS -- Lineage to Present at BTIG Ophthalmology | Paulness | investorshub | 11/29/2022 1:15:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company’s CEO, Brian M. Culley, will present at the 2024 BIO International Convention , on Tue...
Persons with Lived Experience Session Expanded to Include Michaela & Kyle Devins Clinical Session Expanded to Include Neuralink Preclinical Session Expanded to Include Axonis, Novoron, Sania & Rewire Medical Lineage Cell Therapeutics, Inc. (NYSE America...